FDA’s Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds: Is the Bar Being Set Too High, or Too Low?

Lignende værker

• FDA Guidance on 503B Provides Leeway: Outsourcing Facilities Can Be Co-Located With 503A Pharmacies
  af: Barlas, Stephen
  Udgivet: (2018)
• FDA’s New Authority on Drug Shortages
  af: Barlas, Stephen
  Udgivet: (2012)
• Two Draft FDA Guidance Documents Stir Controversy: Hospital and 503B Pharmacy Repackaging and Compounding Are at Issue
  af: Barlas, Stephen
  Udgivet: (2015)
• FDA Draft Guidances Compound the Compounding Uncertainty: A New List of 503B Outsourcing Facilities Offers No Guarantee of Anything
  af: Barlas, Stephen
  Udgivet: (2014)
• FDA’s New Guidelines On Serialized Numerical Identifiers Are Not Helpful to Pharmacies
  af: Barlas, Stephen
  Udgivet: (2010)